RELEEVIA- menthol and capsaicin patch 
Patchwerx Labs, Inc

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Releevia Patch

DESCRIPTION

Releevia Patch contains capsaicin and menthol in a localized dermal delivery system. The capsaicin in Releevia is a synthetic equivalent of the naturally occurring compound found in chili peppers. Capsaicin is soluble in alcohol, acetone, and ethyl acetate and very slightly soluble in water. The menthol is slightly soluble in water.

Releevia is a single-use patch stored in a foil pouch. Each Releevia patch is 8.3 cm x 12.5 cm (104 cm 2) and consists of a polyester backing film coated with a drug-containing silicone adhesive mixture, and covered with a removable polyester release liner.

The empirical formula for capsaicin is C 18H 27NO 3, with a molecular weight of 305.42. The chemical compound capsaicin [(E)-8-methyl-N-vanillyl-6-nonenamide] is an activating ligand for transient receptor potential vanilloid 1 receptor (TRPV1) and it has the following structure:

Figure 1

The empirical formula for menthol is C 10H 20O, with a molecular weight of 156.27. The chemical compound menthol [(1 R,2 S,5 R)-2-isopropyl-5-methylcyclohexanol ] is an activating ligand for transient receptor potential cation channel subfamily M member 8 (TRPM8). It has the following structure:

Menthol chair conformation

Each Releevia Patch contains 0.0375% capsaicin (0.0375 grams of capsaicin per patch) and 5.00% menthol (5 grams of menthol per patch). The Releevia patch contains the following inactive ingredients: Aloe Barbadensis Leaf (Aloe Vera Gel) Juice, Diazolidinyl Urea, EDTA Disodiumm Salt, Glycerin, Iodoproynyl Butylcabamate, Methylparaben, Polysorbate 80, Propylparaben, Sodium Polyacrylate, and Water.

INDICATIONS AND USAGE

Releevia Patch is indicated for the temporary relief of minor aches and muscle pains associated with arthritis, simple backache, strains, muscle soreness and stiffness.

Releevia Patch is an external analgesic/counterirritant.

CONTRAINDICATIONS

Releevia Patch is contraindicated for those patients with a history of hypersensitivity to any of the components of the preparation.

WARNINGS

DOSAGE AND ADMINISTRATION

Releevia patch contains 0.0375% capsaicin and 5.00% menthol.

Instructions for Use

Directions

Adults and children 12 years and over
  • apply to affected area
  • change patch 1 to 2 times daily
Children under 12 years
  • consult physician before use

HOW SUPPLIED

Releevia Patch is supplied in cartons with either 1 re-sealable pouch containing 5 patches or 3 re-sealable pouches each containing 5 patches each.

NDC 69329-025-05 5 Patches per carton

NDC 69329-025-15 15 Patches per carton

Storage: Store below 25°C. Avoid direct sunlight.

Manufactured for


Patchwerx Labs, Inc.

Las Vegas, NV 89118


800-590-8070

Made in USA

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

releevia_label_small

RELEEVIA 
menthol and capsaicin patch
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:69329-025(NDC:69176-025)
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MENTHOL (UNII: L7T10EIP3A) (MENTHOL - UNII:L7T10EIP3A) MENTHOL5 g  in 100 g
CAPSAICIN (UNII: S07O44R1ZM) (CAPSAICIN - UNII:S07O44R1ZM) CAPSAICIN.0375 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
ALOE VERA LEAF (UNII: ZY81Z83H0X)  
DIAZOLIDINYL UREA (UNII: H5RIZ3MPW4)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
GLYCERIN (UNII: PDC6A3C0OX)  
IODOPROPYNYL BUTYLCARBAMATE (UNII: 603P14DHEB)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
POLYSORBATE 80 (UNII: 6OZP39ZG8H)  
PROPYLPARABEN (UNII: Z8IX2SC1OH)  
SODIUM POLYACRYLATE (2500000 MW) (UNII: 05I15JNI2J)  
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:69329-025-1515 in 1 CARTON
1100 g in 1 PATCH
2NDC:69329-025-055 in 1 CARTON
2100 g in 1 PATCH
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other11/17/2014
Labeler - Patchwerx Labs, Inc (079584480)

Revised: 11/2014
Document Id: 07eaac2c-60ae-578b-e054-00144ff8d46c
Set id: 07eaac2c-60ad-578b-e054-00144ff8d46c
Version: 1
Effective Time: 20141115
 
Patchwerx Labs, Inc